Evidence map›Paper›PMID 35908973›Full record

ArticleInternal medicine (Tokyo, Japan)2023

A Tumefactive Fibroinflammatory Lesion of the Head and Neck Mimicking Immunoglobulin G4-related Disease.

Koki Nakamura, Masatoshi Kanda, Kenji Notohara, Masanari Sugawara, Ken Nagahata, Chisako Suzuki, Hiroki Takahashi

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Koki NakamuraDepartment of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Japan.
Masatoshi KandaDepartment of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Japan.
Kenji NotoharaDepartment of Anatomic Pathology, Kurashiki Central Hospital, Japan.
Masanari SugawaraDepartment of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Japan.
Ken NagahataDepartment of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Japan.
Chisako SuzukiDepartment of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Japan.
Hiroki TakahashiDepartment of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Japan.
Sapporo Medical University · JPKurashiki Central Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 67-year-old woman with a 5-year history of recurrent swollen eyelids and epistaxis, diagnosed as immunoglobulin G4-related diseases (IgG4-RD) based on hyper-IgG4-emia and IgG4-positive cell infiltration to the lesion, was referred to our department due to recurrent symptoms despite corticosteroid therapies. Computed tomography revealed an osteoclastic sinus mass with prominent neutrophil infiltration and necrosis that was incompatible with IgG4-RD histopathologically. Finally, she was diagnosed with a tumefactive fibroinflammatory lesion (TFIL) of the head and neck and treated with high-dose corticosteroids. Physicians should remember that TFIL can mimic IgG4-RD in the head and neck region with prominent neutrophil infiltration and necrosis.

Indexed as

Immunoglobulin G4-Related DiseaseAgedDiagnosis, DifferentialFemaleHumansImmunoglobulin GNeckNecrosisImmunoglobulin Gbone destructionIgG4-related diseasesinflammatory pseudotumorsinusitisswollen eyelidstumefactive fibroinflammatory lesion

Identifiers

PMID35908973
PMCPMC10017247
OpenAlexW4288468447

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.